Literature DB >> 24125189

Risk factors for sensorineural hearing loss in chronic otitis media.

Michal Luntz1, Noam Yehudai, Miki Haifler, Gil Sigal, Tova Most.   

Abstract

CONCLUSIONS: Risk factors for sensorineural hearing loss (SNHL) development in patients with chronic otitis media (COM) are longer duration of disease, older age and the presence of cholesteatoma. To prevent the expected development of SNHL, it is imperative to treat COM actively.
OBJECTIVES: To assess the severity of SNHL in patients with unilateral COM and to define risk factors for its development.
METHODS: The study included 317 patients with unilateral COM. Mean age was 28.7 ± 16.7 years (range 7-78 years) and mean duration of disease was 12.2 ± 11.3 years (range 0.25-60 years). In all patients, air conduction (AC) and bone conduction (BC) thresholds in both ears were measured at 500, 1000, 2000 and 4000 Hz. The parameters evaluated were demographics, duration of disease, presence and location of cholesteatoma and otologic history.
RESULTS: The difference in mean BC thresholds between the diseased ears and the healthy ears was statistically significant, ranging from 4.55 ± 10.89 dB to 12.55 ± 19.09 dB across the measured frequency range (p < 0.0001). Multivariate regression analysis revealed statistically significant correlations between advanced age, longer duration of disease and presence of cholesteatoma, and the BC threshold differences between the affected and healthy ears.

Entities:  

Mesh:

Year:  2013        PMID: 24125189     DOI: 10.3109/00016489.2013.814154

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  9 in total

Review 1.  Providing the Best Audiological Care and Creating Sustainability in Peru.

Authors:  Jennifer E Holst; Gabriel A Bargen; Corrie E Holmes
Journal:  Semin Hear       Date:  2020-04-07

2.  Childhood Otitis Media: A Cohort Study With 30-Year Follow-Up of Hearing (The HUNT Study).

Authors:  Lisa Aarhus; Kristian Tambs; Ellen Kvestad; Bo Engdahl
Journal:  Ear Hear       Date:  2015 May-Jun       Impact factor: 3.570

3.  Chronic Conductive Hearing Loss Is Associated With Speech Intelligibility Deficits in Patients With Normal Bone Conduction Thresholds.

Authors:  Masahiro Okada; D Bradley Welling; M Charles Liberman; Stéphane F Maison
Journal:  Ear Hear       Date:  2020 May/Jun       Impact factor: 3.570

Review 4.  Current concepts in the pathogenesis and treatment of chronic suppurative otitis media.

Authors:  Rahul Mittal; Christopher V Lisi; Robert Gerring; Jeenu Mittal; Kalai Mathee; Giri Narasimhan; Rajeev K Azad; Qi Yao; M'hamed Grati; Denise Yan; Adrien A Eshraghi; Simon I Angeli; Fred F Telischi; Xue-Zhong Liu
Journal:  J Med Microbiol       Date:  2015-08-05       Impact factor: 2.472

5.  Micro CT visualization of silver nanoparticles in the middle and inner ear of rat and transportation pathway after transtympanic injection.

Authors:  Jing Zou; Markus Hannula; Superb Misra; Hao Feng; Roberto Hanoi Labrador; Antti S Aula; Jari Hyttinen; Ilmari Pyykkö
Journal:  J Nanobiotechnology       Date:  2015-01-27       Impact factor: 10.435

Review 6.  Inner ear disturbances related to middle ear inflammation.

Authors:  Michihiko Sone
Journal:  Nagoya J Med Sci       Date:  2017-02       Impact factor: 1.131

7.  A program to respond to otitis media in remote Australian Aboriginal communities: a qualitative investigation of parent perspectives.

Authors:  Caroline Jones; Mridula Sharma; Samantha Harkus; Catherine McMahon; Mele Taumoepeau; Katherine Demuth; Karen Mattock; Lee Rosas; Raelene Wing; Sulabha Pawar; Anne Hampshire
Journal:  BMC Pediatr       Date:  2018-03-06       Impact factor: 2.125

8.  Sensorineural damage in chronic suppurative otitis media with and without cholesteatoma: a comparative study.

Authors:  Yiyang Tang; Bing Lian; Mingyan Zhang; Xinfeng Tu; Tao Zhang; Haiyan Wang
Journal:  Ann Transl Med       Date:  2022-07

9.  Chronic Conductive Hearing Loss Leads to Cochlear Degeneration.

Authors:  M Charles Liberman; Leslie D Liberman; Stéphane F Maison
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.